UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K/A
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Amendment No. 1
Date of Report (Date of earliest event reported): January 3, 2005
BRISTOL-MYERS SQUIBB COMPANY
(Exact Name of Registrant as Specified in its Charter)
| | | | | |
| Delaware | | 1-1136 | | 22-079-0350 |
(State or Other
Jurisdiction of
Incorporation) | | (Commission File
Number) | | (IRS Employer
Identification
Number) |
345 Park Avenue
New York, NY, 10154
(Address of Principal Executive Office)
Registrant’s telephone number, including area code: (212) 546-4000
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (seeGeneral Instruction A.2. below):
| | | |
| o | | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| o | | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| o | | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| o | | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
TABLE OF CONTENTS
Explanatory Note:
This Form 8-K/A is filed to include the text of the amendment to Section 15.(a) of the Bylaws of Bristol-Myers Squibb Company, effective as of January 3, 2005, as required by the Form 8-K rules.
Item 9.01. Financial Statements and Exhibits
| | | |
Exhibit No. | | Description |
| | | |
| 3b. | | Section 15.(a) of the Bylaws of Bristol-Myers Squibb Company, effective as of January 3, 2005. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | | |
| | Bristol-Myers Squibb Company |
| | | |
| Date: January 18, 2005 | | |
| | | |
| | By:/s/ Sandra Leung |
| | Name: Sandra Leung |
| | Title: Secretary |
EXHIBIT INDEX
| | | |
Exhibit No. | | Description |
| | | |
| 3b. | | Section 15.(a) of the Bylaws of Bristol-Myers Squibb Company, effective as of January 3, 2005. |
